Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Agid

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Journal of Clinical Psychopharmacology|July 17, 2007
Early use of clozapine for poorly responding first-episode psychosisOfer Agid, Gary Remington, Shitij Kapur, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 13, 2012
Early prediction of clinical and functional outcome in schizophreniaOfer Agid, Cynthia O Siu, Elizabeth Pappadopulos, et al.
The American Journal of Psychiatry|February 5, 2013
Clozapine's role in the treatment of first-episode schizophreniaGary Remington, Ofer Agid, George Foussias, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 12, 2015
Neurocognitive impairment in the deficit subtype of schizophreniaGagan Fervaha, Ofer Agid, George Foussias, et al.
Behavioural Brain Research|August 5, 2021
Schizophrenia: Antipsychotics and drug developmentGary Remington, Margaret K Hahn, Sri Mahavir Agarwal, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 20, 2017
One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysisHiroyoshi Takeuchi, Navot Kantor, Marcos Sanches, et al.
The Journal of Clinical Psychiatry|January 7, 2015
Determinants of patient-rated and clinician-rated illness severity in schizophreniaGagan Fervaha, Hiroyoshi Takeuchi, Ofer Agid, et al.
Psychopharmacology|November 27, 2012
Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?Gary Remington, Ofer Agid, George Foussias, et al.
Journal of Clinical Psychopharmacology|February 14, 2015
Relationship between symptomatic improvement and overall illness severity in patients with schizophreniaGagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, et al.
The Journal of Clinical Psychiatry|February 25, 2017
Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled TrialHiroyoshi Takeuchi, Jimmy Lee, Gagan Fervaha, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Journal of Clinical Psychopharmacology|July 17, 2007
Early use of clozapine for poorly responding first-episode psychosisOfer Agid, Gary Remington, Shitij Kapur, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 13, 2012
Early prediction of clinical and functional outcome in schizophreniaOfer Agid, Cynthia O Siu, Elizabeth Pappadopulos, et al.
The American Journal of Psychiatry|February 5, 2013
Clozapine's role in the treatment of first-episode schizophreniaGary Remington, Ofer Agid, George Foussias, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 12, 2015
Neurocognitive impairment in the deficit subtype of schizophreniaGagan Fervaha, Ofer Agid, George Foussias, et al.
Behavioural Brain Research|August 5, 2021
Schizophrenia: Antipsychotics and drug developmentGary Remington, Margaret K Hahn, Sri Mahavir Agarwal, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 20, 2017
One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysisHiroyoshi Takeuchi, Navot Kantor, Marcos Sanches, et al.
The Journal of Clinical Psychiatry|January 7, 2015
Determinants of patient-rated and clinician-rated illness severity in schizophreniaGagan Fervaha, Hiroyoshi Takeuchi, Ofer Agid, et al.
Psychopharmacology|November 27, 2012
Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?Gary Remington, Ofer Agid, George Foussias, et al.
Journal of Clinical Psychopharmacology|February 14, 2015
Relationship between symptomatic improvement and overall illness severity in patients with schizophreniaGagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, et al.
The Journal of Clinical Psychiatry|February 25, 2017
Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled TrialHiroyoshi Takeuchi, Jimmy Lee, Gagan Fervaha, et al.
Pageof 13